99 related articles for article (PubMed ID: 15767452)
1. Mechanism of the antiviral action of 1-beta-D-arabinofuranosylcytosine on Borna disease virus.
Volmer R; Bajramovic JJ; Schneider U; Ufano S; Pochet S; Gonzalez-Dunia D
J Virol; 2005 Apr; 79(7):4514-8. PubMed ID: 15767452
[TBL] [Abstract][Full Text] [Related]
2. 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread.
Bajramovic JJ; Syan S; Brahic M; de la Torre JC; Gonzalez-Dunia D
J Virol; 2002 Jun; 76(12):6268-76. PubMed ID: 12021360
[TBL] [Abstract][Full Text] [Related]
3. 2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread.
Bajramovic JJ; Volmer R; Syan S; Pochet S; Gonzalez-Dunia D
Antimicrob Agents Chemother; 2004 Apr; 48(4):1422-5. PubMed ID: 15047559
[TBL] [Abstract][Full Text] [Related]
4. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.
Planz O; Pleschka S; Ludwig S
J Virol; 2001 May; 75(10):4871-7. PubMed ID: 11312358
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Borna disease virus to the antiviral action of gamma-interferon: evidence for species-specific differences.
Sauder C; Herpfer I; Hässler C; Staeheli P
Arch Virol; 2004 Nov; 149(11):2171-86. PubMed ID: 15503205
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin inhibits Borna disease virus proliferation and fatal neurological diseases in neonatally infected gerbils.
Lee BJ; Matsunaga H; Ikuta K; Tomonaga K
Antiviral Res; 2008 Dec; 80(3):380-4. PubMed ID: 18778737
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Borna disease virus replication by ribavirin in persistently infected cells.
Mizutani T; Inagaki H; Araki K; Kariwa H; Arikawa J; Takashima I
Arch Virol; 1998; 143(10):2039-44. PubMed ID: 9856091
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Borna disease virus multiplication by interferon: cell line differences in susceptibility.
Hallensleben W; Staeheli P
Arch Virol; 1999; 144(6):1209-16. PubMed ID: 10446654
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Borna disease virus replication by ribavirin.
Jordan I; Briese T; Averett DR; Lipkin WI
J Virol; 1999 Sep; 73(9):7903-6. PubMed ID: 10438889
[TBL] [Abstract][Full Text] [Related]
10. Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial.
Dietrich DE; Bode L; Spannhuth CW; Hecker H; Ludwig H; Emrich HM
BMC Pharmacol Toxicol; 2020 Feb; 21(1):12. PubMed ID: 32066504
[TBL] [Abstract][Full Text] [Related]
11. Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12.
Friedl G; Hofer M; Auber B; Sauder C; Hausmann J; Staeheli P; Pagenstecher A
J Virol; 2004 Feb; 78(3):1212-8. PubMed ID: 14722276
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of Borna disease virus to new host species attributed to altered regulation of viral polymerase activity.
Ackermann A; Staeheli P; Schneider U
J Virol; 2007 Aug; 81(15):7933-40. PubMed ID: 17522214
[TBL] [Abstract][Full Text] [Related]
13. Lack of antiviral effect of amantadine in Borna disease virus infection.
Stitz L; Planz O; Bilzer T
Med Microbiol Immunol; 1998 Mar; 186(4):195-200. PubMed ID: 9574902
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the regulation of the viral polymerase complex of neurotropic Borna disease virus.
Schneider U
Virus Res; 2005 Aug; 111(2):148-60. PubMed ID: 15992626
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of actinomycin D-mediated increase of Borna disease virus (BDV) RNA in cells persistently infected by BDV.
Mizutani T; Inagaki H; Tada M; Hayasaka D; Murphy M; Fujiwara T; Hamada J; Kariwa H; Takashima I
Microbiol Immunol; 2000; 44(7):597-603. PubMed ID: 10981833
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication.
Bourteele S; Oesterle K; Pleschka S; Unterstab G; Ehrhardt C; Wolff T; Ludwig S; Planz O
J Virol; 2005 May; 79(10):6043-51. PubMed ID: 15857990
[TBL] [Abstract][Full Text] [Related]
17. RNA induced polymerization of the Borna disease virus nucleoprotein.
Hock M; Kraus I; Schoehn G; Jamin M; Andrei-Selmer C; Garten W; Weissenhorn W
Virology; 2010 Feb; 397(1):64-72. PubMed ID: 19945724
[TBL] [Abstract][Full Text] [Related]
18. Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling.
Volmer R; Monnet C; Gonzalez-Dunia D
PLoS Pathog; 2006 Mar; 2(3):e19. PubMed ID: 16552443
[TBL] [Abstract][Full Text] [Related]
19. Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus.
Tomonaga K; Kobayashi T; Lee BJ; Watanabe M; Kamitani W; Ikuta K
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12788-93. PubMed ID: 11070091
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
Nakamura K; Eizuru Y; Kumura K; Minamishima Y
J Med Virol; 1990 Jun; 31(2):141-7. PubMed ID: 1696958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
